Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

NCT06751953 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer (CRC)

Interventions

COMBINATION_PRODUCT: Conventional third-line therapy
DRUG: Neoantigen-loaded DC vaccine

Sponsor

The First Affiliated Hospital of Nanchang University